The levels of these cytokines, as well as the increase of pro-inflammatory enzymes such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), are positively regulated by the activation of NF-κB in patients with CKD [41]. Here, NFKB1 is linked to chronic kidney disease.